Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples